25.04.2016 • NewsChinaDede WillamsHMD

Invista Deepens Footprint in China

Mark Evans/Getty Images
Mark Evans/Getty Images

US nylon producer Invista is deepening its footprint in China with the start-up of a new 215,000 t/y plant for hexamethylene diamine (HMD) plant at the Shanghai Chemical Industry Park (SCIP), along with a PTA production line at its joint venture with China Prosperity (Jiangyin) Petrochemical Company, also known as Hanbang Petrochemical.

Invista said the new HMD plant will leverage its most advanced technology to produce the key intermediate for production of PA 6.6 polymer and fiber as well as polyurethanes and high performance nylons.

The unit is part of the company’s new production complex being brought on stream at the Shanghai site, for which groundbreaking ceremonies were held a year ago. Other facilities at the site were planned to include a 150,000 t/y plant for PA 6.6 and a 300,000 t/y plant for adiponitrile (ADN) plant. The total investment of more than $ 1 billion, is said to be the company’s largest ever. China Prosperity’s PTA plant, for which no capacity was disclosed, is the Chinese producer’s second; the first also uses an Invista process.

The new unit will use Invista’s  E2R, Solvent Interchange and R2R technologies, which the nylon specialist said will further enhance its competitiveness in terms of capital productivity, variable cost and environmental performance.

Invista said its Solvent Interchange technology, for which it claims  “inherently low” capital cost, has been successfully deployed with additional advantages achieved through the use of locally manufactured rotary pressure filters. China Prosperity is currently building a polyester resin plant that will use Invista technology.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read